Collagen Type II, Bovine, Soluble

bovine collagen type II (CII) for induction in collagen-induced arthritis (CIA)
Catalog Number: 
5 mL

bovine collagen type II (CII) for induction in CIA from MD Bioproducts

North America: 1-888-USMDBIO
International: +41-44 986 2628

Or you can order by using our online form
Have questions or need bulk? No problem, just ask.

Collagen type II (CII) protein, purified from fetal bovine articular cartilage, for the induction of arthritis in the Collagen-Induced Arthritis (CIA) model.



Type II collagen (CII) is a fibrillar collagen that is primarily located in cartilage tissue. The major molecular form of collagen in cartilage is type II collagen. Type II collagen is also located in the vitreous humor of the eye, the inner ear, the nose, and the intervertebral discs of the spine. The function of type II collagen is to provide tensile strength and give cartilage the ability to resist shearing forces. Mutations of the COL2A1 gene affect the synthesis of type II collagen and cause chondrodysplasias. This is characterized by abnormal cartilage that leads to bone and joint deformities. The degradation of collagen type II is an early indicator of osteoarthritis.


Type II Collagen and Adjuvent Susceptibility to CIA is linked to MHC class II molecules and is dependent upon the species of type II collagen used for immunization. Various species of highly purified Type II Collagen are supplied lyophilized and in solution for use in the induction of arthritis in vivo.


Symbols/Related Terms:


  • COL2A1
  • pro-alpha 1(II) chain
  • Achondrogenesis
  • Hypochondrogenesis
  • Spondyloepimetaphyseal dysplasia
  • Osteoarthritis (OA)
  • Collagen Induced Arthritis (CIA)




Concentration: 2 mg/mL

Purity: >99% as determined by SDS-PAGE and visualized by Coomassie blue staining

Purification: Differential salt precipitation

Source: Fetal bovine articular cartilage

Form: soluble



Bovine Collagen Type II Insert (PDF)


Nieto, F. R., Clark, A. K., Grist, J., Chapman, V., & Malcangio, M. (2015). Calcitonin Gene‐Related Peptide–Expressing Sensory Neurons and Spinal Microglial Reactivity Contribute to Pain States in Collagen‐Induced Arthritis. Arthritis & Rheumatology, 67(6), 1668-1677.


Hansell, C. A., MacLellan, L. M., Oldham, R. S., Doonan, J., Chapple, K. J., Anderson, E. J., & Goodyear, C. S. (2015). The atypical chemokine receptor ACKR2 suppresses Th17 responses to protein autoantigens. Immunology and cell biology, 93(2), 167-176.


Lopes, J. L., Miles, A. J., Whitmore, L., & Wallace, B. A. (2014). Distinct circular dichroism spectroscopic signatures of polyproline II and unordered secondary structures: Applications in secondary structure analyses. Protein Science, 23(12), 1765-1772.


Vogl, T., Eisenblätter, M., Völler, T., Zenker, S., Hermann, S., van Lent, P.,  & Roth, J. (2014). Alarmin S100A8/S100A9 as a biomarker for molecular imaging of local inflammatory activity. Nature communications, 5.


Brühl, H., Cihak, J., Goebel, N., Talke, Y., Renner, K., Hermann, F., & Mack, M. (2014). Chondroitin sulfate activates B cells in vitro, expands CD138+ cells in vivo, and interferes with established humoral immune responses. Journal of leukocyte biology, 96(1), 65-72.


Lindh, I., Snir, O., Lönnblom, E., Uysal, H., Andersson, I., Nandakumar, K. S., & Holmdahl, R. (2014). Type II collagen antibody response is enriched in the synovial fluid of rheumatoid joints and directed to the same major epitopes as in collagen induced arthritis in primates and mice. Arthritis Res Ther, 16(4), R143.


Pineda, M. A., Rodgers, D. T., Al‐Riyami, L., Harnett, W., & Harnett, M. M. (2014). ES‐62 Protects Against Collagen‐Induced Arthritis by Resetting Interleukin‐22 Toward Resolution of Inflammation in the Joints. Arthritis & Rheumatology, 66(6), 1492-1503.


Yilmaz-Elis, A. S., Ramirez, J. M., Asmawidjaja, P., van der Kaa, J., Mus, A. M., Brem, M. D., & Verbeek, J. S. (2014). FcγRIIb on myeloid cells rather than on B cells protects from collagen-induced arthritis. The Journal of Immunology, 192(12), 5540-5547.


Yoshimura, S., Asano, K., & Nakane, A. (2014). Attenuation of collagen-induced arthritis in mice by salmon proteoglycan. BioMed research international, 2014.


Rodgers, D. T., Pineda, M. A., McGrath, M. A., Al‐Riyami, L., Harnett, W., & Harnett, M. M. (2014). Protection against collagen‐induced arthritis in mice afforded by the parasitic worm product, ES‐62, is associated with restoration of the levels of interleukin‐10‐producing B cells and reduced plasma cell infiltration of the joints. Immunology, 141(3), 457-466.


Thiolat, A., Semerano, L., Pers, Y. M., Biton, J., Lemeiter, D., Portales, P. & Bessis, N. (2014). Interleukin‐6 Receptor Blockade Enhances CD39+ Regulatory T Cell Development in Rheumatoid Arthritis and in Experimental Arthritis. Arthritis & Rheumatology, 66(2), 273-283.


Al-Riyami, L., Pineda, M. A., Rzepecka, J., Huggan, J. K., Khalaf, A. I., Suckling, C. J., & Harnett, W. (2013). Designing anti-inflammatory drugs from parasitic worms: a synthetic small molecule analogue of the Acanthocheilonema viteae product ES-62 prevents development of collagen-induced arthritis. Journal of medicinal chemistry, 56(24), 9982-10002.


Campo, G. M., Avenoso, A., D’Ascola, A., Nastasi, G., Micali, A., Puzzolo, D., & Campo, S. (2013). Combined treatment with hyaluronan inhibitor Pep-1 and a selective adenosine A2 receptor agonist reduces inflammation in experimental arthritis. Innate immunity, 19(5), 462-478.


Shashidharamurthy, R., Machiah, D., Aitken, J. D., Putty, K., Srinivasan, G., Chassaing, B., & Vijay‐Kumar, M. (2013). Differential Role of Lipocalin 2 During Immune Complex–Mediated Acute and Chronic Inflammation in Mice. Arthritis & Rheumatism, 65(4), 1064-1073.


Iglesias, M., Postigo, J., Santiuste, I., González, J., Buelta, L., Tamayo, E. & Merino, R. (2013). p27Kip1 inhibits systemic autoimmunity through the control of Treg cell activity and differentiation. Arthritis & Rheumatism, 65(2), 343-354.


Dépis, F., Hatterer, E., Lamacchia, C., Waldburger, J. M., Gabay, C., Reith, W. & Dean, Y. (2012). Long‐term amelioration of established collagen‐induced arthritis achieved with short‐term therapy combining anti‐CD3 and anti–tumor necrosis factor treatments. Arthritis & Rheumatism, 64(10), 3189-3198.


Pineda, M. A., McGrath, M. A., Smith, P. C., Al-Riyami, L., Rzepecka, J., Gracie, J. A., & Harnett, M. M. (2012). The parasitic helminth product ES-62 suppresses pathogenesis in CIA by targeting of the IL-17-producing cellular network at multiple sites. Arthritis Rheum, 64(10), 3168-3178.


Presumey, J., Salzano, G., Courties, G., Shires, M., Ponchel, F., Jorgensen, C & De Rosa, G. (2012). PLGA microspheres encapsulating siRNA anti-TNFalpha: efficient RNAi-mediated treatment of arthritic joints. European Journal of Pharmaceutics and Biopharmaceutics, 82(3), 457-464.


Clark, A. K., Grist, J., Al‐Kashi, A., Perretti, M., & Malcangio, M. (2012). Spinal cathepsin S and fractalkine contribute to chronic pain in the collagen‐induced arthritis model. Arthritis & Rheumatism, 64(6), 2038-2047.


Crilly, A., Palmer, H., Nickdel, M. B., Dunning, L., Lockhart, J. C.Plevin, R., & Ferrell, W. R. (2012). Immunomodulatory role of proteinase-activated receptor-2. Annals of the rheumatic diseases, 71(9), 1559-1566.


Roy, L. D., Ghosh, S., Pathangey, L. B., Tinder, T. L., Gruber, H. E., & Mukherjee, P. (2011). Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancer. Bmc Cancer, 11(1), 365.


Campo, G. M., Avenoso, A., Nastasi, G., Micali, A., Prestipino, V., Vaccaro, M., & Campo, S. (2011). Hyaluronan reduces inflammation in experimental arthritis by modulating TLR-2 and TLR-4 cartilage expression. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1812(9), 1170-1181.


Bonnefoy, F., Couturier, M., Clauzon, A., Rémy-Martin, J. P., Gaugler, B., Tiberghien, P. & Perruche, S. (2011). TGF-β–Exposed Plasmacytoid Dendritic Cells Participate in Th17 Commitment. The Journal of Immunology, 186(11), 6157-6164.



How the purified bovine collagen type II (bCII) protein was used:
A Virus-Like Particle-Based Anti-Nerve Growth Factor Vaccine Reduces Inflammatory Hyperalgesia: Potential Long-Term Therapy for Chronic Pain
Rohn, T et al., J. Immunol., Feb 2011; 186: 1769
RA was induced by intradermal injection of collagen type II in CFA followed by an intradermal injection of collagen type II in IFA 21 d later.
Pan-CC chemokine neutralization restricts splenocyte egress and reduces inflammation in a model of arthritis.
Buatois V, et al. J immunol. 2010 Aug 15; 185(4):2544-54.
Induce arthritis in mice.
Liver X Receptor Agonism Promotes Articular Inflammation in Murine Collagen-Induced Arthritis
Asquith DL, Miller AM, et al. Arthritis Rheum. 2009 Sep; 60(9):2655-65.
Induce arthritis in male DBA/1 mice at 7-8 weeks of age. On day 0, mice were injected intradermally with 100 ug of bCII/CFA emulsification. On day 21, 200 ug bCII/PBS was injected intraperitoneally.
Destructive Arthritis in the Absence of Both FcRI and FcRIII
Peter Boross et al., J. Immunol., Apr 2008; 180: 5083 - 5091.
Induce arthritis in male mice. Mice were immunized at the tail base with 100 ug of bCII emulsified in CFA. A boost was given on day 28 with 100 ug of bCII emulsified in IFA. Additionally, bCII protein was used as a plate-coating reagent to create an ELISA to measure anti-bCII antibodies.
Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes.
Khoury M, et al. Arthritis Rheum. 2008 Aug; 58(8):2356-67
Induce arthritis in 9 week-old male DBA/1 mice.
Immunomodulatory Dendritic Cells Inhibit Th1 Responses and Arthritis via Different Mechanisms
Leonie M. van Duivenvoorde et al., J. Immunol., Aug 2007; 179: 1506 - 1515.

Induce arthritis in male DBA/1J mice. Mice were immunized at the tail base with 100 ug of bCII emulsified in CFA. A boost was given three weeks later with 100 ug of bCII emulsified in IFA.

Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis.
Trachsel E, et al. Arthritis Res Ther. 2007;9(1):R9
Induce arthritis in male DBA/1 mice (8-12 weeks' old). Mice were immunized at the tail base with 200 ug of bCII emulsified in CFA. A boost was given two weeks later with 200 ug of bCII emulsified in IFA.

The non-thiol angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis
N. Dalbeth et al., Rheumatology, Jan 2005; 44: 24 - 31.

Induce arthritis in adult male DBA/101aHsd mice. Mice were immunized at the base of the tail with 100 ug of bCII emulsified in CFA.
Inflammatory arthritis and dermatitis in thymectomized, CD25+ cell-depleted adult mice
A. Loughry et al., Rheumatology, Mar 2005; 44: 299 - 308.
Induce arthritis in male DBA/1j mice. Mice were immunized at the tail base with 100 ug of bCII emulsified in CFA.

Tracking of Proinflammatory Collagen-Specific T Cells in Early and Late Collagen-Induced Arthritis in Humanized Mice
Pia Svendsen et al., J. Immunol., Dec 2004; 173: 7037 - 7045.

Induce arthritis in genetically modified mice on a DBA1/J background. Mice were immunized at the tail base with 100 - 150 ug of bCII emulsified in CFA. A boost was given on day 40 with 50 - 100 ug of CII emulsified in IFA.


How To Use

How To Use: 

Key Applicatons:


  • Induction of arthritis in vivo
  • Attachment and differentiation of chondrocytes
  • Cell culture
  • ELISA standard/plate coating